Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2011 6
2012 4
2013 6
2015 3
2016 1
2017 4
2018 10
2019 11
2020 5
2021 9
2022 10
2023 7
2024 6
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators. Eikelboom JW, et al. N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28844192 Free article. Clinical Trial.
RESULTS: The primary outcome occurred in fewer patients in the rivaroxaban-plus-aspirin group than in the aspirin-alone group (379 patients [4.1%] vs. 496 patients [5.4%]; hazard ratio, 0.76; 95% confidence interval [CI], 0.66 to 0.86; P<0.001; z=-4.126), but major blee …
RESULTS: The primary outcome occurred in fewer patients in the rivaroxaban-plus-aspirin group than in the aspirin-alone group (379 patients …
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
Aggarwal R, Heller G, Hillman DW, Xiao H, Picus J, Taplin ME, Dorff T, Appleman L, Weckstein D, Patnaik A, Bryce A, Shevrin D, Mohler J, Anderson D, Rao A, Tagawa S, Tan A, Halabi S, Dooley K, O'Brien P, Chen R, Ryan CJ, Eggener SE, Morris MJ; EORTC-55994 Study Group. Aggarwal R, et al. J Clin Oncol. 2024 Apr 1;42(10):1114-1123. doi: 10.1200/JCO.23.01157. Epub 2024 Jan 23. J Clin Oncol. 2024. PMID: 38261983 Free PMC article. Clinical Trial.
Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.
Hashemi L, Marijic Buljubasic A, Budoff MJ, Copeland LA, Jackson NJ, Jasuja GK, Gornbein J, Reue K. Hashemi L, et al. JAMA Netw Open. 2024 Jul 1;7(7):e2419696. doi: 10.1001/jamanetworkopen.2024.19696. JAMA Netw Open. 2024. PMID: 38954413 Free PMC article.
MAIN OUTCOMES AND MEASURES: Metabolic syndrome z-scores were calculated based on body mass index, systolic blood pressure, and levels of high-density lipoprotein cholesterol, triglycerides, and blood glucose. Changes in mean z-scores were compared among the transgen …
MAIN OUTCOMES AND MEASURES: Metabolic syndrome z-scores were calculated based on body mass index, systolic blood pressure, and levels …
Using Z Boson Events to Study Parton-Medium Interactions in Pb-Pb Collisions.
Sirunyan AM, Tumasyan A, Adam W, Ambrogi F, Bergauer T, Dragicevic M, Erö J, Escalante Del Valle A, Frühwirth R, Jeitler M, Krammer N, Lechner L, Liko D, Madlener T, Mikulec I, Pitters FM, Rad N, Schieck J, Schöfbeck R, Spanring M, Templ S, Waltenberger W, Wulz CE, Zarucki M, Chekhovsky V, Litomin A, Makarenko V, Suarez Gonzalez J, Darwish MR, De Wolf EA, Di Croce D, Janssen X, Kello T, Lelek A, Pieters M, Rejeb Sfar H, Van Haevermaet H, Van Mechelen P, Van Putte S, Van Remortel N, Blekman F, Bols ES, Chhibra SS, D'Hondt J, De Clercq J, Lontkovskyi D, Lowette S, Marchesini I, Moortgat S, Morton A, Python Q, Tavernier S, Van Doninck W, Van Mulders P, Beghin D, Bilin B, Clerbaux B, De Lentdecker G, Dorney B, Favart L, Grebenyuk A, Kalsi AK, Makarenko I, Moureaux L, Pétré L, Popov A, Postiau N, Starling E, Thomas L, Vander Velde C, Vanlaer P, Vannerom D, Wezenbeek L, Cornelis T, Dobur D, Gruchala M, Khvastunov I, Niedziela M, Roskas C, Skovpen K, Tytgat M, Verbeke W, Vermassen B, Vit M, Bruno G, Bury F, Caputo C, David P, Delaere C, Delcourt M, Donertas IS, Giammanco A, Lemaitre V, Mondal K, Prisciandaro J, Taliercio A, Teklishyn M, Vischia P, Wuyckens S, Zobec J, Alves GA, Correia S… See abstract for full author list ➔ Sirunyan AM, et al. Phys Rev Lett. 2022 Mar 25;128(12):122301. doi: 10.1103/PhysRevLett.128.122301. Phys Rev Lett. 2022. PMID: 35394329 Free article.
Hadronic collision data with one reconstructed Z boson candidate with the transverse momentum p_{T}>30 GeV/c are analyzed. The Z boson constrains the initial energy and direction of the associated parton. ...The measurements of the fragmentation functions and p_{ …
Hadronic collision data with one reconstructed Z boson candidate with the transverse momentum p_{T}>30 GeV/c are analyzed. The …
A multi-dimensional search for new heavy resonances decaying to boosted W W , W Z , or Z Z boson pairs in the dijet final state at 13 Te .
Sirunyan AM, Tumasyan A, Adam W, Ambrogi F, Bergauer T, Brandstetter J, Dragicevic M, Erö J, Del Valle AE, Flechl M, Frühwirth R, Jeitler M, Krammer N, Krätschmer I, Liko D, Madlener T, Mikulec I, Rad N, Schieck J, Schöfbeck R, Spanring M, Spitzbart D, Waltenberger W, Wulz CE, Zarucki M, Drugakov V, Mossolov V, Gonzalez JS, Darwish MR, De Wolf EA, Di Croce D, Janssen X, Lauwers J, Lelek A, Pieters M, Sfar HR, Van Haevermaet H, Van Mechelen P, Van Putte S, Van Remortel N, Blekman F, Bols ES, Chhibra SS, D'Hondt J, De Clercq J, Lontkovskyi D, Lowette S, Marchesini I, Moortgat S, Moreels L, Python Q, Skovpen K, Tavernier S, Van Doninck W, Van Mulders P, Van Parijs I, Beghin D, Bilin B, Brun H, Clerbaux B, De Lentdecker G, Delannoy H, Dorney B, Favart L, Grebenyuk A, Kalsi AK, Luetic J, Popov A, Postiau N, Starling E, Thomas L, Velde CV, Vanlaer P, Vannerom D, Cornelis T, Dobur D, Khvastunov I, Niedziela M, Roskas C, Trocino D, Tytgat M, Verbeke W, Vermassen B, Vit M, Zaganidis N, Bondu O, Bruno G, Caputo C, David P, Delaere C, Delcourt M, Giammanco A, Lemaitre V, Magitteri A, Prisciandaro J, Saggio A, Marono MV, Vischia P, Zobec J, Alves FL, Alves GA, Silva GC, Hensel C, Moraes A, Te… See abstract for full author list ➔ Sirunyan AM, et al. Eur Phys J C Part Fields. 2020;80(3):237. doi: 10.1140/epjc/s10052-020-7773-5. Epub 2020 Mar 12. Eur Phys J C Part Fields. 2020. PMID: 32215380 Free PMC article.
A search in an all-jet final state for new massive resonances decaying to W W , W Z , or Z Z boson pairs using a novel analysis method is presented. The analysis is performed on data corresponding to an integrated luminosity of 77.3 fb-1 recorded with the CMS …
A search in an all-jet final state for new massive resonances decaying to W W , W Z , or Z Z boson pairs using a novel …
Variability of CLMI-X parameters, zonal Kmax, and single-point Kmax in keratoconus progression.
Hashemi H, Asgari S, Mahmoud AM, Mehravaran S, Roberts CJ. Hashemi H, et al. Eye (Lond). 2023 Oct;37(15):3197-3202. doi: 10.1038/s41433-023-02476-1. Epub 2023 Mar 14. Eye (Lond). 2023. PMID: 36918626 Free PMC article.

In the KC group, Sw were significantly different between Cspot-Axi and Kmax (p < 0.0001), and between Z-Kmax3 and Kmax (p < 0.0001). In the Z-Kmax3 50.0D subgroup, Sw were different between Cspot-Axi and Kmax (p = 0.0002). In the Z-Kmax3 > 50.0D subg

…

In the KC group, Sw were significantly different between Cspot-Axi and Kmax (p < 0.0001), and between Z-Kmax3 and Kmax (p < 0.0

…
Identification of (Z)-2,3-Diphenylacrylonitrileas Anti-Cancer Molecule in Persian Gulf Sea Cucumber Holothuria parva.
Amidi S, Hashemi Z, Motallebi A, Nazemi M, Farrokhpayam H, Seydi E, Pourahmad J. Amidi S, et al. Mar Drugs. 2017 Oct 16;15(10):314. doi: 10.3390/md15100314. Mar Drugs. 2017. PMID: 29035293 Free PMC article.
Furthermore, the methanolic extract of H. parva was investigated furthermore and the active fraction was extracted. In this fraction, (Z)-2,3-diphenylacrylonitrile molecule, which is also known as alpha-cyanostilbene, was identified by mass analysis. ...These results sugge …
Furthermore, the methanolic extract of H. parva was investigated furthermore and the active fraction was extracted. In this fraction, (Z …
Functions of TIP60/NuA4 Complex Subunits in Cell Differentiation.
Hashemi F, Nourozi A, Loushab MS, Riabowol K. Hashemi F, et al. Cells. 2025 Nov 1;14(21):1720. doi: 10.3390/cells14211720. Cells. 2025. PMID: 41227365 Free PMC article. Review.
We emphasize the molecular mechanisms by which TIP60/NuA4 shapes lineage specification, including histone H2A and H4 acetylation by the KAT5 catalytic subunit, H2A.Z incorporation by EP400, and interactions with transcription factors such as MyoD, PPARgamma, and Myc. ...
We emphasize the molecular mechanisms by which TIP60/NuA4 shapes lineage specification, including histone H2A and H4 acetylation by the KAT5 …
Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose Osimertinib.
Zwierenga F, Muntinghe-Wagenaar MB, Rozendal P, de Langen AJ, Hendriks LEL, van den Heuvel M, van der Leest C, Hashemi SMS, van der Leest P, Hiltermann TJN, Schuuring E, van der Wekken AJ. Zwierenga F, et al. Target Oncol. 2025 Jul;20(4):663-677. doi: 10.1007/s11523-025-01153-5. Epub 2025 Jun 5. Target Oncol. 2025. PMID: 40473885 Free PMC article.
Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development.
Alavian SM, Ande SR, Coombs KM, Yeganeh B, Davoodpour P, Hashemi M, Los M, Ghavami S. Alavian SM, et al. J Viral Hepat. 2011 Dec;18(12):821-30. doi: 10.1111/j.1365-2893.2011.01530.x. Epub 2011 Oct 13. J Viral Hepat. 2011. PMID: 22093031 Review.
Emerging data indicate that autophagy plays an important role in some liver diseases including liver injury induced by ischaemia reperfusion and alpha-1 antitrypsin Z allele-dependent liver disease. Autophagy may also occur in viral infection, and it may play a crucial rol …
Emerging data indicate that autophagy plays an important role in some liver diseases including liver injury induced by ischaemia reperfusion …
90 results